Literature DB >> 2154501

Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors.

K Sawada1, S B Krantz, C H Dai, S T Koury, S T Horn, A D Glick, C I Civin.   

Abstract

To facilitate the direct study of the molecular events that control the development of human burst-forming units-erythroid (BFU-E), we have developed a method to purify BFU-E from peripheral blood. Using density centrifugation, rosetting with a mixture of neuraminidase-treated and IgG-coated sheep erythrocytes, positive panning with anti-My10 monoclonal antibody, overnight adherence to plastic dishes, negative panning with monoclonal antibodies, and density centrifugation, human blood BFU-E were purified from 0.04% to 56.6%, a 1,400-fold purification with a 13% yield. More than 90% of purified BFU-E were recombinant interleukin-3 (rIL-3) dependent, which survived for 48 h with rIL-3 in the absence of recombinant erythropoietin (rEP), and 80% gave rise to erythroid bursts of more than 500 hemoglobinized cells. rEP dependency was not evident until after 72 h of incubation in vitro. The purified cells (day 1) were incubated with rIL-3 and rEP in liquid culture for 24 (day 2), 48 (day 3), and 72 (day 4) h and then were transferred into semisolid cultures and incubated until day 15. The size of the erythroid colonies observed in semisolid cultures decreased continuously in association with the incubation time of day 1 purified cells in liquid cultures. The first appearance of colony-forming units-erythroid (CFU-E) that gave rise to colonies of 8 to 49 cells was observed after 72 h of incubation of day 1 cells in the liquid culture. 125I-rEP was incubated for 5 h at 37 degrees C with purified cells (day 1) or with the cells that had been incubated in liquid culture for an additional 24-72 h, and the presence of erythropoietin (EP) receptors was investigated using autoradiography. Specific binding of 125I-rEP was detected in 19 +/- 7% of the initial day 1 BFU-E. The percentage of 125I-rEP-binding to erythroid progenitor cells and the amount of binding continuously increased as day 1 BFU-E matured. 125I-rEP specific binding was observed with all of the erythroid progenitor cells that had been incubated in liquid culture for 72 h. These data demonstrate that primitive BFU-E have a much lower number of EP receptors than CFU-E and develop an increased concentration of EP receptors in association with their maturation and loss of proliferative capacity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154501     DOI: 10.1002/jcp.1041420202

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  26 in total

1.  HIF1alpha synergizes with glucocorticoids to promote BFU-E progenitor self-renewal.

Authors:  Johan Flygare; Violeta Rayon Estrada; Chanseok Shin; Sumeet Gupta; Harvey F Lodish
Journal:  Blood       Date:  2010-12-21       Impact factor: 22.113

Review 2.  Oxygen delivery enhancers: past, present, and future.

Authors:  P Borrione; A Mastrone; R A Salvo; A Spaccamiglio; L Grasso; A Angeli
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

3.  CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells.

Authors:  Yong-Mei Guo; Keiko Ishii; Makoto Hirokawa; Hiroyuki Tagawa; Hideaki Ohyagi; Yoshihiro Michishita; Kumi Ubukawa; Junsuke Yamashita; Toshiaki Ohteki; Nobuyuki Onai; Kazuyoshi Kawakami; Weiguo Xiao; Kenichi Sawada
Journal:  Blood       Date:  2010-03-26       Impact factor: 22.113

4.  Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E.

Authors:  Jie Li; John Hale; Pooja Bhagia; Fumin Xue; Lixiang Chen; Julie Jaffray; Hongxia Yan; Joseph Lane; Patrick G Gallagher; Narla Mohandas; Jing Liu; Xiuli An
Journal:  Blood       Date:  2014-10-22       Impact factor: 22.113

5.  A 'bottom-up' approach for endo-PK/PD analysis.

Authors:  S Neelakantan; J A Widness; R L Schmidt; P Veng-Pedersen
Journal:  Biopharm Drug Dispos       Date:  2006-10       Impact factor: 1.627

Review 6.  MicroRNAs: Allies or foes in erythropoiesis?

Authors:  John C H Byon; Thalia Papayannopoulou
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

7.  Pharmacodynamic analysis of stress erythropoiesis: change in erythropoietin receptor pool size following double phlebotomies in sheep.

Authors:  Mohammad I Saleh; John A Widness; Peter Veng-Pedersen
Journal:  Biopharm Drug Dispos       Date:  2011-01-10       Impact factor: 1.627

Review 8.  Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease.

Authors:  Robert Deicher; Walter H Hörl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Increased erythropoietin elimination in fetal sheep following chronic phlebotomy.

Authors:  Kevin J Freise; John A Widness; Jeffrey L Segar; Robert L Schmidt; Peter Veng-Pedersen
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

10.  Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo.

Authors:  M A Goldsmith; A Mikami; Y You; K D Liu; L Thomas; P Pharr; G D Longmore
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.